P
ISSUER//CIK 0001714798
Prevail Therapeutics Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A73.1 KBPrevail Therapeutics Inc.Feb 16, 4:39 PM ET·0001104659-21-024244
- SC 13G/A159.8 KBPrevail Therapeutics Inc.Feb 16, 4:30 PM ET·0001104659-21-024136
- SC 13G/A48.1 KBPrevail Therapeutics Inc.Feb 12, 4:19 PM ET·0001193125-21-041576
- SC 13G/A46.8 KBPrevail Therapeutics Inc.Feb 12, 4:06 PM ET·0000935836-21-000106
- SC 13G206.7 KBPrevail Therapeutics Inc.Jan 29, 4:15 PM ET·0001123292-21-000143
- SC 13D/A76.1 KBPrevail Therapeutics Inc.Jan 28, 8:30 PM ET·0000947871-21-000118
- 8-K112.0 KBPrevail Therapeutics Inc.Jan 22, 9:25 AM ET·0001193125-21-014276
- SC TO-T/A88.0 KBPrevail Therapeutics Inc.Jan 22, 9:02 AM ET·0001193125-21-014250
- SC 13D93.5 KBPrevail Therapeutics Inc.Dec 22, 8:49 AM ET·0001193125-20-323947
- 8-K789.8 KBPrevail Therapeutics Inc.Dec 15, 9:12 AM ET·0001193125-20-317624
Insiders
10- Abeliovich AsaDirector, President & CEO, 10% Owner
- Adams Timothy MDirector
- Carson William H.Director
- Dai YongChief Technology Officer
- ELI LILLY & Co10% Owner
- GORDON CARL LDirector, 10% Owner
- Hefti FranzChief Development Officer
- Kaplan BrettChief Financial Officer
- Minkow EmilyChief Business Officer
- Nader FrancoisDirector
Tickers
No tickers on record
Addresses
business
430 EAST 29TH STREET, SUITE 940
NEW YORK, NY, 10016
mailing
430 EAST 29TH STREET, SUITE 940
NEW YORK, NY, 10016